These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1949080)

  • 21. Fluoroquinolone antibacterials enhance UVA-induced skin tumors.
    Klecak G; Urbach F; Urwyler H
    J Photochem Photobiol B; 1997 Feb; 37(3):174-81. PubMed ID: 9085564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UV-dependent quinolone-induced human erythrocyte membrane lipid peroxidation: studies on the phototoxicity of Y-26611, a new quinolone derivative.
    Wada K; Saniabadi AR; Umemura K; Takiguchi Y; Nakashima M
    Pharmacol Toxicol; 1994; 74(4-5):240-3. PubMed ID: 8090693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of prostaglandin production by quinolone phototoxicity in Balb/c 3T3 mouse fibroblast cells in vitro.
    Shimoda K; Wagai N; Kato M
    Fundam Appl Toxicol; 1997 Apr; 36(2):157-62. PubMed ID: 9143485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro phototoxic activities of new quinolone antibacterial agents: lipid peroxidative potentials.
    Fujita H; Matsuo I
    Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):202-5. PubMed ID: 7880759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A predictive mouse ear-swelling model for investigating topical phototoxicity.
    Gerberick GF; Ryan CA
    Food Chem Toxicol; 1989 Dec; 27(12):813-9. PubMed ID: 2606411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliability of phototoxic tests of fluoroquinolones in vitro.
    Zhang T; Li JL; Ma XC; Xin J; Tu ZH
    Acta Pharmacol Sin; 2003 May; 24(5):453-9. PubMed ID: 12740182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
    Fukuda H; Kawamura Y
    Jpn J Antibiot; 2002 Jun; 55(3):270-80. PubMed ID: 12199111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo photochemical micronucleus induction due to certain quinolone antimicrobial agents in the skin of hairless mice.
    Itoh S; Katoh M; Furuhama K
    Mutat Res; 2002 Sep; 520(1-2):133-9. PubMed ID: 12297153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pefloxacin and ciprofloxacin increase UVA-induced edema and immune suppression.
    Sun YW; Heo EP; Cho YH; Bark KM; Yoon TJ; Kim TH
    Photodermatol Photoimmunol Photomed; 2001 Aug; 17(4):172-7. PubMed ID: 11499539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Concentrations of new quinolone agents in serum and prostate tissue].
    Imai K; Suzuki K; Yamanaka H; Makino T; Yazima H; Takezawa Y; Kitaura K; Shiono A; Sato J; Kato N
    Hinyokika Kiyo; 1994 May; 40(5):401-6. PubMed ID: 7517621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental evaluation of cyadox phototoxicity to Balb/c mouse skin.
    He Q; Fang G; Wang Y; Wei Z; Wang D; Zhou S; Fan S; Yuan Z
    Photodermatol Photoimmunol Photomed; 2006 Apr; 22(2):100-4. PubMed ID: 16606415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LD50 value, phototoxicity and convulsion induction test of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)]-9-fluoro-2, 3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyl ic acid hemihydrate in laboratory animals.
    Shimoda K; Akahane K; Nomura M; Kato M
    Arzneimittelforschung; 1996 Jun; 46(6):625-8. PubMed ID: 8767355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents.
    Umezawa N; Arakane K; Ryu A; Mashiko S; Hirobe M; Nagano T
    Arch Biochem Biophys; 1997 Jun; 342(2):275-81. PubMed ID: 9186488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on quinolone antibacterials. IV. Structure-activity relationships of antibacterial activity and side effects for 5- or 8-substituted and 5,8-disubstituted-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-1, 4-dihydro-4-oxoquinoline-3-carboxylic acids.
    Yoshida T; Yamamoto Y; Orita H; Kakiuchi M; Takahashi Y; Itakura M; Kado N; Mitani K; Yasuda S; Kato H; Itoh Y
    Chem Pharm Bull (Tokyo); 1996 May; 44(5):1074-85. PubMed ID: 8689718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photohaptenic properties of fluoroquinolones.
    Tokura Y; Nishijima T; Yagi H; Furukawa F; Takigawa M
    Photochem Photobiol; 1996 Nov; 64(5):838-44. PubMed ID: 8931383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of quinolone phototoxicity.
    Shimoda K
    Toxicol Lett; 1998 Dec; 102-103():369-73. PubMed ID: 10022281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A predictive mouse ear-swelling model for investigating topical photoallergy.
    Gerberick GF; Ryan CA
    Food Chem Toxicol; 1990 May; 28(5):361-8. PubMed ID: 2379895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of skin phototoxicity with three drugs by an in vivo mouse model.
    Matsumoto N; Akimoto A; Kawashima H; Kim S
    J Toxicol Sci; 2010 Feb; 35(1):97-100. PubMed ID: 20118629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of antioxidants, anti-inflammatory drugs, and histamine antagonists on sparfloxacin-induced phototoxicity in mice.
    Shimoda K; Nomura M; Kato M
    Fundam Appl Toxicol; 1996 May; 31(1):133-40. PubMed ID: 8998949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte stimulation test with drug-photomodified cells in patients with quinolone photosensitivity.
    Tokura Y; Seo N; Ohshima A; Yagi H; Furukawa F; Takigawa M
    J Dermatol Sci; 1999 Sep; 21(1):34-41. PubMed ID: 10468190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.